Development and approval of novel injectables: enhancing therapeutic innovations
Authors:
- 2 April 2024
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 21 (4) , 639-662
Abstract
Novel injectables possess applications in both local and systemic therapeutics delivery. The advancement in utilized materials for construction of complex injectables has tremendously upgraded their safety and efficacy. This review focuses on various strategies to produce novel injectables, including oily dispersions, in situ forming implants, injectable suspensions, microspheres, liposomes, and antibody-drug conjugates. We herein present a detailed description of complex injectable technologies and their related drug formulations permitted for clinical use by the United States Food and Drug Administration (USFDA). The excipients used, their purpose and the challenges faced during manufacturing such formulations have been critically discussed. Novel injectables can deliver therapeutic agents in a controlled way at the desired site. However, several challenges persist with respect to their genericization. Astronomical costs incurred by innovator companies during product development, complexity of the product itself, supply limitations with respect to raw materials, intricate manufacturing processes, patent evergreening, product life-cycle extensions, relatively few and protracted generic approvals contribute to the exorbitant prices and access crunch. Moreover, regulatory guidance are grossly underdeveloped and significant efforts have to be directed toward development of effective characterization techniques.Keywords
This publication has 77 references indexed in Scilit:
- Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection SiteAdvances in Therapy, 2019
- Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystalsAdvanced Drug Delivery Reviews, 2017
- Oily (Lipophilic) Solutions and Suspensions2011
- Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspectsAdvanced Drug Delivery Reviews, 2008
- Phase transformation considerations during process development and manufacture of solid oral dosage formsAdvanced Drug Delivery Reviews, 2004
- Kinetic and thermodynamic modeling of the formation of polymeric microspheres using solvent extraction/evaporation methodJournal of Controlled Release, 1995
- Release and absorption rates of intramuscularly and subcutaneously injected pharmaceuticals (II)International Journal of Pharmaceutics, 1994
- Sterically stabilized liposomesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1992
- Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation timesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Drug release from lipid-based dosage forms. IIInternational Journal of Pharmaceutics, 1980